Cargando…

More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease

Activation of the β-adrenergic receptor (βAR) pathway is the main mechanism of the heart to increase cardiac output via protein kinase A (PKA)-mediated phosphorylation of cellular target proteins, and perturbations therein may contribute to cardiac dysfunction in heart failure. In the present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamdani, Nazha, Borbély, Attila, Veenstra, Sophie P. G. R., Kooij, Viola, Vrydag, Wim, Zaremba, Ruud, dos Remedios, Cris, Niessen, Hans W. M., Michel, Martin C., Paulus, Walter J., Stienen, Ger J. M., van der Velden, Jolanda
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005110/
https://www.ncbi.nlm.nih.gov/pubmed/21132354
http://dx.doi.org/10.1007/s10974-010-9231-8
_version_ 1782194066974310400
author Hamdani, Nazha
Borbély, Attila
Veenstra, Sophie P. G. R.
Kooij, Viola
Vrydag, Wim
Zaremba, Ruud
dos Remedios, Cris
Niessen, Hans W. M.
Michel, Martin C.
Paulus, Walter J.
Stienen, Ger J. M.
van der Velden, Jolanda
author_facet Hamdani, Nazha
Borbély, Attila
Veenstra, Sophie P. G. R.
Kooij, Viola
Vrydag, Wim
Zaremba, Ruud
dos Remedios, Cris
Niessen, Hans W. M.
Michel, Martin C.
Paulus, Walter J.
Stienen, Ger J. M.
van der Velden, Jolanda
author_sort Hamdani, Nazha
collection PubMed
description Activation of the β-adrenergic receptor (βAR) pathway is the main mechanism of the heart to increase cardiac output via protein kinase A (PKA)-mediated phosphorylation of cellular target proteins, and perturbations therein may contribute to cardiac dysfunction in heart failure. In the present study a comprehensive analysis was made of mediators of the βAR pathway, myofilament properties and cardiac structure in patients with idiopathic (IDCM; n = 13) and ischemic (ISHD; n = 10) cardiomyopathy in comparison to non-failing hearts (donor; n = 10) for the following parameters: βAR density, G-coupled receptor kinases 2 and 5, stimulatory and inhibitory G-proteins, phosphorylation of myofilament targets of PKA, protein phosphatase 1, phospholamban, SERCA2a and single myocyte contractility. All parameters exhibited the expected alterations of heart failure, but for most of them the extent of alteration was greater in IDCM than in ISHD. Histological analysis also revealed higher collagen in IDCM compared to ISHD. Alterations in the βAR pathway are more pronounced in IDCM than in ISHD and may reflect sequential changes in cellular protein composition and function. Our data indicate that cellular dysfunction is more severe in IDCM than in ISHD.
format Text
id pubmed-3005110
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-30051102011-01-19 More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease Hamdani, Nazha Borbély, Attila Veenstra, Sophie P. G. R. Kooij, Viola Vrydag, Wim Zaremba, Ruud dos Remedios, Cris Niessen, Hans W. M. Michel, Martin C. Paulus, Walter J. Stienen, Ger J. M. van der Velden, Jolanda J Muscle Res Cell Motil Original Paper Activation of the β-adrenergic receptor (βAR) pathway is the main mechanism of the heart to increase cardiac output via protein kinase A (PKA)-mediated phosphorylation of cellular target proteins, and perturbations therein may contribute to cardiac dysfunction in heart failure. In the present study a comprehensive analysis was made of mediators of the βAR pathway, myofilament properties and cardiac structure in patients with idiopathic (IDCM; n = 13) and ischemic (ISHD; n = 10) cardiomyopathy in comparison to non-failing hearts (donor; n = 10) for the following parameters: βAR density, G-coupled receptor kinases 2 and 5, stimulatory and inhibitory G-proteins, phosphorylation of myofilament targets of PKA, protein phosphatase 1, phospholamban, SERCA2a and single myocyte contractility. All parameters exhibited the expected alterations of heart failure, but for most of them the extent of alteration was greater in IDCM than in ISHD. Histological analysis also revealed higher collagen in IDCM compared to ISHD. Alterations in the βAR pathway are more pronounced in IDCM than in ISHD and may reflect sequential changes in cellular protein composition and function. Our data indicate that cellular dysfunction is more severe in IDCM than in ISHD. Springer Netherlands 2010-12-04 2010 /pmc/articles/PMC3005110/ /pubmed/21132354 http://dx.doi.org/10.1007/s10974-010-9231-8 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Paper
Hamdani, Nazha
Borbély, Attila
Veenstra, Sophie P. G. R.
Kooij, Viola
Vrydag, Wim
Zaremba, Ruud
dos Remedios, Cris
Niessen, Hans W. M.
Michel, Martin C.
Paulus, Walter J.
Stienen, Ger J. M.
van der Velden, Jolanda
More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
title More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
title_full More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
title_fullStr More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
title_full_unstemmed More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
title_short More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
title_sort more severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005110/
https://www.ncbi.nlm.nih.gov/pubmed/21132354
http://dx.doi.org/10.1007/s10974-010-9231-8
work_keys_str_mv AT hamdaninazha moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT borbelyattila moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT veenstrasophiepgr moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT kooijviola moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT vrydagwim moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT zarembaruud moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT dosremedioscris moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT niessenhanswm moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT michelmartinc moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT pauluswalterj moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT stienengerjm moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease
AT vanderveldenjolanda moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease